Диссертация (1145861), страница 16
Текст из файла (страница 16)
2006. Т. 11. С. 1673-83.119.Portela A., Esteller M. Epigenetic modifications and human disease// Nat Biotechnol. 2010. Т. 10. С. 1057-68.120.Prince M., Prina M., Guerchet M. World Alzheimer Report2013. Journey of Caring, An analysis of long-term care for dementia [Эелктронныйресурс] // ALZ.CO.UK, 2013& URL: http://www.alz.co.uk/research/world-report-2013(дата обращения: 24.06.14).121.Ramsahoye B.H., Biniszkiewicz D., Lyko F., Clark V., Bird A.P.,Jaenisch R. Non-CpG methylation is prevalent in embryonic stem cells and may bemediated by DNA methyltransferase 3a // PNAS. 2000.
Т. 97. № 10. С. 5237-42.99122.Reddy Т. P., Zhu X., Perry G. and Smith M.A. Oxidative stress indiabetes and Alzheimer’s disease // J Alzheimers Dis. 2009. Т. 16. С. 763-774.123.Relkin N., Szabo P., Adamiak B., Burgut T., Monthe C., Lent R.W.,Younkin S., Younkin L., Schiff R., Weksler M.E. 18-Month study of intravenousimmunoglobulin for treatment of mild Alzheimer disease // Neurobiol. Aging. 2009. Т.30. № 11. С. 1728-36124.Roberds S.L., Anderson J., Basi G., Bienkowski M.J., BranstetterD.G., Chen K.S., Freedman S.B., Frigon N.L., Games D., Hu K., Johnson-Wood K.,Kappenman K.E., Kawabe T.T., Kola I., Kuehn R., Lee M., Liu W., Motter R., NicholsN.F., Power M., Robertson D.W., Schenk D., Schoor M., Shopp G.M., Shuck M.E.,Sinha S., Svensson K.A., Tatsuno G., Tintrup H., Wijsman J., Wright S., McConlogueL.
BACE knockout mice are healthy despite lacking the primary beta-secretase activityin brain: implications for Alzheimer's disease therapeutics // Hum Mol Genet. 2001. Т.10. № 12. С. 1317-24.125.Rouaux C., Jokic N., Mbebi C., Boutillier S., Loeffler J.P., BoutillierA.L. Critical loss of CBP/p300 histone acetylase activity by caspase-6 duringneurodegeneration // EMBO J.
2003. Т. 22. С. 6537–6549.126.Rovelet-Lecrux A., Hannequin D., Raux G., Meur N., LaquerrièreA., Vital A., Dumanchin C., Feuillette S., Brice A., Vercelletto M., Dubas F., FrebourgT., Campion D. APP locus duplication causes autosomal dominant early-onsetAlzheimer disease with cerebral amyloid angiopathy // Nature Genetics. 2006. № 38. С.24-26.127.Salloway S. Sperling R., Keren R., Porsteinsson A.P., van DyckC.H., Tariot P.N., Gilman S., Arnold D., Abushakra S., Hernandez C., Crans G., LiangE., Quinn G., Bairu M., Pastrak A., Cedarbaum J.M. Investigators A phase 2randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer Disease //Neurology. 2011. Т.
77. С. 1253–1262.128.Samuels S., Davis K. Experimental approaches to cognitivedisturbance in Alzheimer's disease // Harv Rev Psychiatry. 1998. Т. 6. № 1. С. 11-22.100129.Sarantseva S., Timoshenko S., Bolshakova O., Karaseva E., RodinD., Schwarzman A.L. and Vitek M.С.
Apolipoprotein E-mimetics inhibit neurodegeneration and restore cognitive functions in a transgenic Drosophila model of Alzheimer’sdisease // PLOS One. 2009. Т. 7. e8191.130.Saura C.A., Choi S.-Y., Beglopoulos Т., Malkani S., Zhang D., RaoB.S.S., Chattarji S., Kelleher J., Kandel E.R., Duff K., Kirkwood A., Shen J. Loss ofpresenilin function causes impairments of memory and synaptic plasticity followed byage-dependent neurodegeneration // Neuron.
2004. Т. 42. С. 23–36.131.Scheff S.W., Price D.A. Alzheimer's disease-related alterations insynaptic density: neocortex and hippocampus // J Alzheimers Dis. 2006. Т. 9. № 3. С.101-15.132.Schenk D., Barbour R., Dunn W. Immunization with amyloid-betaattenuates Alzheimer-disease-like pathology in PDAPP mouse // Nature. 1999.
Т. 400.С. 173–177.133.Shimmyo Y., Kihara T., Akaike A., Niidome T., Sugimoto H.Epigallocatechin-3-gallate and curcumin suppress amyloid beta-induced beta-site APPcleaving enzyme-1 upregulation // Neuroreport. 2008. Т. 19. С. 1329–1333.134.Smith A.D. The worldwide challenge of the dementias: a role for Bvitamins and homocysteine // Food Nutr Bull. 2008 . Т.
29. № 2. С. 143-72.135.Stante M., Minopoli G., Passaro F., Raia M., Vecchio L.D. andRusso T. Fe65 is required for Tip60-di- rected histone H4 acetylation at DNA strandbreaks // Proceedings of the National Academy of Sciences of the United States ofAmerica. 2009. Т. 106. С. 5093-5098.136.Stefani M.
and Liguri G. Cholesterol in Alzheimer’s disease:unresolved questions // Curr Alzheimer Res .2009. Т. 6. С. 15-29.137.Su B., Wang X., Nunomura A., Moreira P.I., Lee H.G., Perry G.,Smith M.A., Zhu X. Oxidative stress signaling in Alzheimer's disease // Curr AlzheimerRes. 2008. Т. 5. № 6. С. 525-32.101138.Sze C.I., Bi H., Kleinschmidt-DeMasters B.K., Filley C.M., MartinL.J. Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer'sdisease brains // J Neurol Sci. 2000. Т.
175. №2. С. 81-90.139.Szumiel I. and Foray N. Chromatin acetylation, β-amyloid precursorprotein and its binding partner FE65 in DNA double strand break repair // ActaBiochimica Polonica. 2011. Т. 58. С. 8-11.140.Terry R.D. The pathogenesis of Alzheimer disease: an alternative tothe amyloid hypothesis // J. Neuropathol. ExС. Neurol. 1996. Т. 55.
С. 1023–1025.141.Terry R.D., Masliah E. and Salmon D.С. Physical basis of cognitivealterations in alzheimer’s disease: Synapse loss is the major correlate of cognitiveimpair- ment // Annals of Neurology. 1991. Т. 30. С. 572-580.142.Thambisetty M., Simmons A., Velayudhan L., Hye A., Campbell J.,Zhang Y., Wahlund L.O., Westman E., Kinsey A., Güntert A., Proitsi P., Powell J.,Causevic M., Killick R., Lunnon K., Lynham S., Broadstock M., Choudhry F., HowlettDR., Williams R.J., Sharp S.I., Mitchelmore C., Tunnard C., Leung R., Foy C., O'BrienD., Breen G., Furney S.J., Ward M., Kloszewska I., Mecocci P., Soininen H., TsolakiM., Vellas B., Hodges A., Murphy D.G., Parkins S., Richardson J.C., Resnick S.M.,Ferrucci L., Wong D.F., Zhou Y., Muehlboeck S., Evans A., Francis P.T., Spenger C.,Lovestone S. Association of plasma clusterin concentration with severity, pathology,and progression in Alzheimer disease // Arch.
Gen. Psychiatry. 2010. Т. 67. №7. С.739-48.143.Thome J., Retz W., Baader M., Pesold B., Hu M., Cowen M.,Durany N., Adler G., Henn F.A., Rösler M. Association analysis of HTR6 and HTR2Apolymorphisms in sporadic Alzheimer's disease // J Neural Transm. 2001. Т. 108. №10С. 1175-80.144.Tohgi H., Utsugisawa K., Nagane Y., Yoshimura M., Genda Y.Ukitsu M.
Reduction with age in methylcytosine in the promoter region -224approximately -101 of the amyloid precursor protein gene in autopsy human cortex //Brain Res. Mol. Brain Res. 1999. Т. 70 С. 288–292.102145.Torroja L., Packard M., Gorczyca M., White K. and Bud-nik Т. TheDrosophila b-amyloid precursor protein homolog promotes synapse differentiation atthe neuromuscular junction // The Journal of Neuroscience. 1999. Т. 15. С. 7793-7803.146.Townsend M., Cleary J.P., Mehta T., Hofmeister J., Lesne S.,O’Hare E., Walsh D.M., Selkoe D.J. Orally available compound prevents deficits inmemory caused by the Alzheimer Amyloid-b oligomers // Ann Neurol.
2006. Т. 60. С.668–676.147.Townsend K.С. and Pratico` D. Novel therapeutic opportunities forAlzheimer’s disease: focus on nonsteroidal anti-inflammatory drugs // FASEB J . 2005.Т. 19. С. 1592-1601.148.Umeda T., Mori H., Zheng H., Tomiyama T. Regulation ofcholesterol efflux by amyloid beta secretion // J Neurosci Res. 2010. Т. 88. №9. С.1985-94.149.Walker J. R. Pacoma R., Watson J., Ou W., Alves J., Mason D.E.,Peters E.C., Urbina H.D., Welzel G., Althage A., Liu B., Tuntland T., Jacobson L.H.,Harris J.L., Schumacher A.M.
Enhanced proteolytic clearance of plasma Aβ byperipherally administered neprilysin does not result in reduced levels of brain Aβ inmice // J. Neurosci. 2013. Т. 33. С. 2457–2464.150.Walsh D.M., Klyubin I., Fadeeva J.Т. Cullen W.K., Anwyl R.,Wolfe M.S., Rowan M.J., Selkoe D.J. Naturally secreted oligomers of amyloid betaprotein potently inhibit hippocampal long-term potentiation in vivo // Nature. 2002. Т.416.
С. 535-539.151.Walsh D.M., Selkoe D.J. A beta oligomers - a decade of discovery //J Neurochem . 2007. Т. 101. С. 1172–1184.152.Walsh D.M., Selkoe D.J. Deciphering the molecular basis ofmemory failure in Alzheimer's disease // Neuron. 2004. Т. 44. №1. С. 181-93.153.Wang W.X. Rajeev B.W., Stromberg A.J., Ren N., Tang G., HuangQ., Rigoutsos I., Nelson P.T. The expression of microRNA miR-107 decreases early inAlzheimer's disease and may accelerate disease progression through regulation of beta-103site amyloid precursor protein-cleaving enzyme 1// J Neurosci .2008.
Т. 28. С. 1213–1223.154.Wang Y., Tang X.C., Zhang H.Y. Huperzine A Alleviates SynapticDeficits and Modulates Amyloidogenic and Nonamyloidogenic Pathways in APPswe/PS1dE9 Transgenic Mice // J Neurosci Res. 2012. Т. 90. №2. С. 508-17.155.Wang S.C., Oelze B., Schumacher A. Age-specific epigenetic driftin late-onset Alzheimer’s disease // PLoS One. 2008. Т. 3. №7. e2698.156.Xia W., Wong S.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
